Scarica l'app Stockscreener
75.04
0.17%
0.13
Dopo l'orario di chiusura:
75.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$74.91
Aprire:
$74.93
Volume 24 ore:
2.28M
Relative Volume:
0.85
Capitalizzazione di mercato:
$16.75B
Reddito:
$4.04B
Utile/perdita netta:
$557.10M
Rapporto P/E:
31.13
EPS:
2.4102
Flusso di cassa netto:
$916.70M
1 W Prestazione:
+0.31%
1M Prestazione:
+0.23%
6M Prestazione:
+8.79%
1 anno Prestazione:
+17.95%
Intervallo 1D:
$74.93
$75.10
Intervallo di 1 settimana:
$74.84
$75.26
Portata 52W:
$51.90
$75.36
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.04 | 16.72B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
485.84 | 169.97B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
175.89 | 50.58B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.20 | 38.58B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.55 | 37.11B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.55 | 35.80B | 5.40B | 1.49B | 1.78B | 10.12 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-12 | Downgrade | Argus | Buy → Hold |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Aggiornamento | Argus | Hold → Buy |
| 2025-08-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-27 | Reiterato | Needham | Hold |
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Can Hologic Inc. scale operations efficientlyTrade Entry Summary & Daily Profit Maximizing Trade Tips - mfd.ru
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now? - Yahoo! Finance Canada
Hologic, Inc. $HOLX Shares Sold by Wealthfront Advisers LLC - MarketBeat
Illinois Municipal Retirement Fund Purchases 29,143 Shares of Hologic, Inc. $HOLX - MarketBeat
Is Wall Street bullish or bearish on Hologic stock? - MSN
How The Narrative Surrounding Hologic (HOLX) Has Shifted With The US$79 All Cash Buyout - Yahoo Finance
Hologic, Inc. $HOLX is Sound Shore Management Inc CT's 9th Largest Position - MarketBeat
What are analysts’ price targets for Hologic Inc.Watch List & Weekly Breakout Watchlists - mfd.ru
Hologic, Inc. $HOLX Shares Sold by Allianz Asset Management GmbH - MarketBeat
China regulator approves Blackstone, TPG acquisition of medtech firm Hologic - Reuters
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Is Wall Street Bullish or Bearish on Hologic Stock? - Barchart.com
Is Hologic (HOLX) Pricing Reflect Its Cash Flow Strength After Recent Stability In Diagnostics? - simplywall.st
Azzad Asset Management Inc. ADV Trims Position in Hologic, Inc. $HOLX - MarketBeat
Bone Mineral Densitometry (BMD) Market is expected to reach US$ - openPR.com
China approves Blackstone, TPG acquisition of medtech firm Hologic - The Economic Times
China market regulator: approved Blackstone and TPG's acquisition of medical technology company Hologic - marketscreener.com
Market Fear: Whats the profit margin of Hologic Inc2025 Technical Patterns & Smart Swing Trading Alerts - baoquankhu1.vn
Twin Capital Management Inc. Cuts Position in Hologic, Inc. $HOLX - MarketBeat
Nuance Investments LLC Sells 1,017,410 Shares of Hologic, Inc. $HOLX - MarketBeat
US Market Recap: Does Hologic Inc have a sustainable dividendJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Hologic, Inc. $HOLX Holdings Cut by IQ EQ FUND MANAGEMENT IRELAND Ltd - MarketBeat
Hologic, Inc. (HOLX) Announces Shareholder Approval for Merger w - GuruFocus
Hologic Shareholders Approve Blackstone and TPG Buyout Deal - TipRanks
SA's Competition Commission approves proposed deal whereby Hopper parent intends to buy Hologic, without conditions - marketscreener.com
Hologic’s Aptima assay secures FDA approval for HPV primary screening - Medical Device Network
Machina Capital S.A.S. Buys 13,426 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic’s Aptima HPV assay receives FDA approval for primary screening By Investing.com - Investing.com Nigeria
Hologic Goes Global: Can International Expansion Offset China and Africa Headwinds? - Smartkarma
FDA Approves Hologic’s Aptima HPV Assay Primary Screening Option - Medical Product Outsourcing
Hologic receives FDA approval for Aptima® HPV assay primary screening option, expanding cervical health portfolio - marketscreener.com
Hologic Says US FDA Approves Aptima HPV Testing Assay - marketscreener.com
Hologic’s Aptima HPV assay receives FDA approval for primary screening - Investing.com
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health PortfolioHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic Receives FDA Approval for Aptima HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio - Business Wire
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hologic (HOLX) and Irhythm Technologies (IRTC) - The Globe and Mail
United States Bone Densitometer Devices Market is expected - openPR.com
National Pension Service Grows Position in Hologic, Inc. $HOLX - MarketBeat
New York State Common Retirement Fund Grows Stock Holdings in Hologic, Inc. $HOLX - MarketBeat
Robert Olstein's Strategic Moves: Exiting Hologic Inc with a -1.44% Impact - Yahoo Finance
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Hologic (HOLX) International Revenue Performance Explored - Yahoo Finance
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Hologic, Inc. (HOLX) Stock Analysis: Unpacking Growth Potential Amidst a Hold Rating Consensus - DirectorsTalk Interviews
Is Hologic Inc vulnerable to short sellersMarket Activity Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
(HOLX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Market Outlook: What are analysts price targets for Hologic Inc2025 Price Momentum & Weekly Top Performers Watchlists - baoquankhu1.vn
Hologic (HOLX) Q1 2026 Margin Compression Reinforces Cautious Community Narratives - Sahm
Evercore ISI Adjusts Hologic Price Target to $76 From $78, Maintains In Line Rating - marketscreener.com
Hologic Q1 comes up short of Street expectations ahead of sale to private equity - MassDevice
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.58%
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):